UBS has given British American Tobacco (BAT) a "Neutral" rating and a target price of 2800 pence after the company's recent Capital Markets Day. Analyst Faham Baig mentioned that BAT has confirmed its medium-term financial goals, indicating progress and confidence in meeting its commitments.
UBS's assessment reflects their perspective on BAT's performance and outlook, emphasizing the tobacco company's strategic direction and financial stability. The report, published on October 17, 2024, highlights the importance of BAT's ongoing initiatives in the changing market landscape.